These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 1933695)
1. Treatment of Alzheimer's disease: hopes and reality. Gauthier S; Gauthier L; Bouchard R; Quirion R; Sultan S Can J Neurol Sci; 1991 Aug; 18(3 Suppl):439-41. PubMed ID: 1933695 [TBL] [Abstract][Full Text] [Related]
2. Cholinergic approaches to the treatment of Alzheimer's disease. Hollander E; Mohs RC; Davis KL Br Med Bull; 1986 Jan; 42(1):97-100. PubMed ID: 3006861 [No Abstract] [Full Text] [Related]
3. No response to high-dose muscarinic agonist therapy in Alzheimer's disease. Mouradian MM; Mohr E; Williams JA; Chase TN Neurology; 1988 Apr; 38(4):606-8. PubMed ID: 3281057 [TBL] [Abstract][Full Text] [Related]
4. Effects of cholinergic enhancement therapies on memory function in Alzheimer's disease: a meta-analysis of the literature. Jorm AF Aust N Z J Psychiatry; 1986 Jun; 20(2):237-40. PubMed ID: 3464268 [TBL] [Abstract][Full Text] [Related]
5. [Cholinergic agents in the treatment of Alzheimer's disease]. Zemishlany Z; Davidson M; Davis KL Harefuah; 1987 Dec; 113(12):401-4. PubMed ID: 3330722 [No Abstract] [Full Text] [Related]
6. Cholinergic drugs in Alzheimer's disease. Davis KL; Mohs RC N Engl J Med; 1986 Nov; 315(20):1286-7. PubMed ID: 3773941 [No Abstract] [Full Text] [Related]
7. Clinical trials with the cholinergic drug RS 86 in Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT). Wettstein A; Spiegel R Psychopharmacology (Berl); 1984; 84(4):572-3. PubMed ID: 6441959 [TBL] [Abstract][Full Text] [Related]
8. Cholinergic treatments for Alzheimer's disease. Roberts F; Lazareno S Biochem Soc Trans; 1989 Feb; 17(1):76-9. PubMed ID: 2653922 [No Abstract] [Full Text] [Related]
9. Treatment of Alzheimer's disease with cholinergic drugs. Kumar V; Calache M Int J Clin Pharmacol Ther Toxicol; 1991 Jan; 29(1):23-37. PubMed ID: 2004862 [TBL] [Abstract][Full Text] [Related]
10. The treatment of cognitive impairment in Alzheimer's disease: beyond the cholinergic approach. Davidson M; Stern RG Psychiatr Clin North Am; 1991 Jun; 14(2):461-82. PubMed ID: 2062728 [TBL] [Abstract][Full Text] [Related]
12. [The effects of cholinergic preparations in Alzheimer's disease]. Bradley RJ; Edge MT; Freeman AM Farmakol Toksikol; 1991; 54(3):4-10. PubMed ID: 1915820 [No Abstract] [Full Text] [Related]
13. Clinical drug trials in Alzheimer's disease. Crook T Ann N Y Acad Sci; 1985; 444():428-36. PubMed ID: 3893271 [No Abstract] [Full Text] [Related]
14. Muscarinic agonist therapy of Alzheimer's disease. A clinical trial of RS-86. Bruno G; Mohr E; Gillespie M; Fedio P; Chase TN Arch Neurol; 1986 Jul; 43(7):659-61. PubMed ID: 3524514 [TBL] [Abstract][Full Text] [Related]
15. Approaches to rational drug development in Alzheimer's disease. Iversen LL; Iversen SD; Freedman SB; Dawson G; Rupniak N; Hargreaves RJ; Showell GA; Street LJ; Baker R Drug Des Discov; 1993; 9(3-4):251-9. PubMed ID: 8400006 [No Abstract] [Full Text] [Related]
16. Are drugs targeted at Alzheimer's disease useful? 2. Insufficient evidence of worthwhile benefit. Byrne EJ; Arie T BMJ; 1990 Apr; 300(6732):1132-3; discussion 1131. PubMed ID: 2160850 [No Abstract] [Full Text] [Related]
17. [Cholinergic treatment strategies in Alzheimer's disease]. Kurz A; Rüster P; Romero B; Zimmer R Nervenarzt; 1986 Oct; 57(10):558-69. PubMed ID: 3785472 [No Abstract] [Full Text] [Related]